Critical Outcome Technologies Inc.

(COT:CX2)

By |

Profile

Critical Outcome Technologies Inc is a biopharmaceutical company advancing the treatment of cancer through targeted therapeutics. Its compound COTI-2 has a novel p53-dependent mechanism of action with selective and potent anti-cancer activity.

Contact Information

Website: www.criticaloutcome.com
Email: gkelly@criticaloutcome.com
Main Phone: +1 519 858-5157
Address: 700 Collip Circle
Address 2: Suite 213
State: ON
City / Town: London
Country: CAN
Postal Code: N6G 4X8

Issuer Information

Exchange: CDX
Employees: 6
NAICS: Pharmaceutical P
$ 0.92 $ -0.04 (-4.17%)
Last Price 0.92 Change $ -0.04 Change % -4.17 Tick N/A
Bid N/A Bid Size 0.00 Ask N/A Ask Size 0.00
Open 0.92 High 0.92 Low 0.92 Prev Close 0.96
Last Trade Volume 500 52 Wk Hi 6.40 52 Wk Low 0.95
Market Cap 15.4 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 16,686,968.00 EPS (TTM) -0.35 PE Ratio N/A Exchange TSXV
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 1.5 1.5 1.5 1.5
Low Target Price Estimate 1.5 1.5 1.5 1.5
Mean Target Price Estimate 1.5 1.5 1.5 1.5
Standard Deviation 0 0 0 0
Date of Most Recent Estimate 08/17/16 08/17/16 08/17/16 08/17/16
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 0 0 0 1
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 0 0 0 1